Company: NCNA
Filing Date: 2025-04-04
Form Type: DRS
Source: 0000950123-25-003335
Chunk: 103

Company: NuCana plc
Filing Date: 2025-04-04
Form: DRS
Chunk 103
---
                                                                                                                |
| 19.1   |     | Insider Trading Policy (incorporated by reference to Exhibit 19.1 of the Company’s Annual Report on Form 20-F, filed with the SEC on March 20, 2025).                                                                                                      |
| 21.1   |     | Subsidiaries of the registrant (incorporated by reference to Exhibit 21.1 of the Company’s Registration Statement on Form F-1/A, filed with the SEC on September 1, 2017).                                                                                 |
| 23.1*  |     | Consent of Ernst & Young LLP, registrant’s independent registered public accounting firm.                                                                                                                                                                  |
| 23.2*  |     | Consent of Bristows LLP (included in Exhibit 5.1).                                                                                                                                                                                                         |
| 24.1*  |     | Power of Attorney (included on signature page to the registration statement).                                                                                                                                                                              |
| 97.1   |     | Clawback Policy, adopted by the registrant on December 1, 2023 (incorporated by reference to Exhibit 97.1 of the Company’s Annual Report on Form 20-F, filed with the SEC on                                                                               
 March 20, 2025).                                                                                                                                                                                                                                           |
| 107*   |     | Filing Fee Table.                                                                                                                                                                                                                                          |

| * | To be filed by amendment. |

| 

# | Indicates management contract or compensatory plan. |
| † | Confidential treatment has been requested as to portions of this exhibit. Confidential treatment materials have 
 been omitted and filed separately with the SEC.                                                                 |

| + | Certain portions of the exhibits that are not material and would be competitively harmful if publicly disclosed 
 have been redacted. Copies of the unredacted exhibits will be furnished to the SEC upon request.                |

II-3

Confidential Treatment Requested by Nucana plc Pursuant to 17 C.F.R. Section 200.83 (b) Financial Statement Schedules All Schedules have been omitted because the information required to be presented in them is not applicable or is shown in the consolidated financial statements or related notes incorporated by reference herein.

| Item 9. | Undertakings |

(a) The undersigned registrant hereby undertakes: (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: (i) To include any prospectus required by Section 10